Christopher Yoo Ph.D Overview

  • Primary Position
  • Founder & Chief...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 5

  • Med. Deal Size

  • Med. Valuation

Christopher Yoo Ph.D General Information

Biography

Dr. Christopher Yoo is the Founder and serves as Chief Executive Officer at Yoo & Co Accelerator. He serves as a Board Member at CRISPRQC. He is a Co-Founder and serves as Chief Technology Officer & Board Member at Systems Oncology. He also serves as a Board member at Lenoss Medical. He is the Founding Partner and serves as a General Partner at Xcellerant Ventures. He serves as a Board Member at Nanodropper. He is also a Co-Founder of Systems Imagination and serves as its Chief Executive Officer. He also is the Founder and serves as President and Chief Executive Officer at Yoo and Company. Previously he served as President and Chief Executive Officer at MedTrust Online. He has over 25 years of experience in advancing cutting-edge biomedical information technology. He is the founder and CEO of Systems Imagination, Inc., which offers advanced cognitive computing technology to translate big data into valuable insights. At IBM, he was instrumental as Head of Strategy and Planning for IBM's Information Based Medicine business, a new unit that pioneered the infusion of high-performance computing and research into the developing fields of personalized medicine and molecular therapeutics based on genomics. Throughout his career, he has also held leadership positions at Cisco, Oracle, and Applied Biosystems. As a serial entrepreneur, he has created value in new companies that accelerate the adoption of smarter, technology-based systems such as cognitive computing, big data analytics, and knowledge engineering. He has founded and successfully engineered the exit of startups including MedTrust Online, the world's first and largest online community of cancer doctors treating difficult cases with molecular medicine knowledge. He has also founded Golden Gateway Partners, a trans-Pacific technology consulting company, TransMed Partners, the first boutique consultancy for translational medicine, and LabBook, the first electronic laboratory notebook for HCLS researchers. In addition to his leadership roles at Systems Oncology and Systems Imagination, he is also a Faculty Associate in the College of Health Solutions at Arizona State University. He received his Ph.D. in Cell and Molecular Biology from Yale University and completed his postdoctoral fellowship at UC Berkeley.

Contact Information

Primary Position
Founder & Chief Executive Officer, Yoo & Co Accelerator
Education
University of California, Berkeley, Post Doctoral
Yale University, Ph.D. (Doctor of Philosophy)
University of Pennsylvania, BS (Bachelor of Science)
Gender
Male
Address
  • 3110 North Central Avenue
  • Street D-153
  • Phoenix, AZ 85012
  • United States

Christopher Yoo Ph.D Positions (4)

Firm name Firm type Title Location Industry Since
ReSuture Company Board Member & Strategy Director Surprise, AZ Surgical Devices
Systems Oncology Company Co-Founder, Chief Technology Officer & Board Member Scottsdale, AZ Drug Discovery
Xcellerant Ventures Investor Founding Partner & General Partner Scottsdale, AZ Venture Capital
Yoo & Co Accelerator Investor Founder & Chief Executive Officer Phoenix, AZ Accelerator/Incubator

Christopher Yoo Ph.D Board Seats (5)

Company Industry Ownership Status Financing Status Location Since
CRISPR QC Other Healthcare Technology Systems Privately Held (backing) Venture Capital-Backed San Diego, CA
Lenoss Medical Other Devices and Supplies Privately Held (backing) Venture Capital-Backed Providence, RI
Nanodropper Other Devices and Supplies Privately Held (backing) Venture Capital-Backed Rochester, MN
ReSuture Surgical Devices Privately Held (backing) Venture Capital-Backed Surprise, AZ
Systems Oncology Drug Discovery Privately Held (backing) Venture Capital-Backed Scottsdale, AZ

Christopher Yoo Ph.D Lead Partner on Deals (5)

Christopher Yoo Ph.D has been the lead partner on 5 deals. Their latest deal was with CRISPR QC, a other healthcare technology systems company. The deal was made for on 02-Apr-2025.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
CRISPR QC 02-Apr-2025 Early Stage VC (Series A1) Completed Other Healthcare Technology Systems San Diego, CA
Lenoss Medical 13-Dec-2023 Completed Other Devices and Supplies Providence, RI
ReSuture 06-Jun-2021 Completed Surgical Devices Surprise, AZ
Nanodropper 19-Apr-2021 Seed Round Completed Other Devices and Supplies Rochester, MN
Nanodropper Accelerator/Incubator Completed Other Devices and Supplies Rochester, MN

Christopher Yoo Ph.D Network (34)

Board Members (21)

Name Company Representing Location From
Dominique Messerli Lenoss Medical Lenoss Medical Providence, RI
Seema Phull Nanodropper Golden Seeds Rochester, MN
Systems Oncology Self Scottsdale, AZ
Nanodropper Nanodropper Rochester, MN
Systems Oncology The Pritzker Organization Scottsdale, AZ

Portfolio Executives (11)

Name Company Role Deal date Location
Tim Cloutier Ph.D CRISPR QC Chief Commercial Officer 02-Apr-2025 San Diego, CA
Kiana Aran Ph.D CRISPR QC Co-Founder & Board Member 02-Apr-2025 San Diego, CA
CRISPR QC Co-Founder, Chief Executive Officer, President & Board Member 02-Apr-2025 San Diego, CA
Lenoss Medical Co-Founder, Chief Executive Officer, President & Chairman 13-Dec-2023 Providence, RI
ReSuture Co-Founder, Chief Operating Officer & Board Member 06-Jun-2021 Surprise, AZ

Fund Team Members (2)

Name Investor Fund Fund Location
Xcellerant Ventures Scottsdale, AZ
Xcellerant Ventures Scottsdale, AZ

Christopher Yoo Ph.D Affiliated Funds (1)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Xcellerant Fund 3 Xcellerant Ventures Venture - General Open 2023

Christopher Yoo Ph.D FAQs

  • Who is Christopher Yoo Ph.D?

    Dr. Christopher Yoo is the Founder and serves as Chief Executive Officer at Yoo & Co Accelerator.

  • How much does Christopher Yoo Ph.D typically invest?

    Christopher Yoo Ph.D's median deal size is .

  • What is Christopher Yoo Ph.D’s main position?

    Christopher Yoo Ph.D’s primary position is Founder & Chief Executive Officer.

  • How many active board seats does Christopher Yoo Ph.D hold?

    Christopher Yoo Ph.D holds 5 board seats including CRISPR QC, Lenoss Medical, Nanodropper, ReSuture, and Systems Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »